Evidence map›Paper›PMID 36501211›Full record

Trial reportNutrients2022

Evaluation of a Dietary Supplementation Combining Protein and a Pomegranate Extract in Older People: A Safety Study.

Valérie Dormal, Barbara Pachikian, Elena Debock, Marine Buchet, Sylvie Copine, Louise Deldicque

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Valérie DormalCenter of Investigation in Clinical Nutrition, Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.
Barbara PachikianCenter of Investigation in Clinical Nutrition, Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.
Elena DebockCenter of Investigation in Clinical Nutrition, Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.
Marine BuchetCenter of Investigation in Clinical Nutrition, Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.
Sylvie CopineCenter of Investigation in Clinical Nutrition, Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID 0000-0001-7118-727X
Louise DeldicqueCenter of Investigation in Clinical Nutrition, Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID 0000-0003-3393-5278
UCLouvain · BE

Funding

Région Wallonne Delicens
6 · The paper itself

Abstract

Malnutrition is a highly prevalent condition in older adults. It is associated with low muscle mass and function and increased occurrence of health problems. Maintaining an adequate nutritional status as well as a sufficient nutrient intake in older people is therefore essential to address this public health problem. For this purpose, protein supplementation is known to prevent the loss of muscle mass during aging, and the consumption of various pomegranate extracts induces numerous health benefits, mainly through their antioxidant properties. However, to our knowledge, no study has to date investigated the impact of their combination on the level of malnutrition in older people. The objective of this preliminary study was thus to evaluate the safety of a combination of protein and a pomegranate extract in healthy subjects aged 65 years or more during a 21-day supplementation period. Thirty older participants were randomly assigned to receive protein and a pomegranate extract (Test group) or protein and maltodextrin (Control group) during a 21-day intervention period. The primary outcomes were the safety and tolerability of the supplementation defined as the occurrence of adverse events, and additional secondary outcomes included physical examination and hematological and biochemical parameters. No serious adverse events were reported in any group. Changes in physical, hematological, and biochemical parameters between the initial screening and the end of the study were equivalent in both groups, except for glutamate-pyruvate transaminase (GPT) and prealbumin, for which a decrease was observed only in the Test group. Our initial findings support the safety of the combination of protein and a pomegranate extract in healthy elderly people. Future clinical trials on a larger sample and a longer period are needed to determine the efficacy of this combination.

Indexed as

Dietary SupplementsMalnutritionAgedAntioxidantsDietary ProteinsHumansPlant ExtractsAntioxidantsDietary ProteinsPlant Extractsclinical trialolder peoplepomegranate extractproteinsafety

Identifiers

PMID36501211
PMCPMC9739468
OpenAlexW4311630641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.